PTCA.us – Angioplasty and stenting digest.

Guidant battle signals another brisk year for biotech mergers

January 16, 2006   Categories: Uncategorized  Posted by admin

Strong profits, low interest rates, and hordes of cash have sparked a wave of mergers that underlie Boston Scientific’s battle to buy a rival medical device maker.

Merger and acquisitions last year topped $1 trillion nationally, the most since 2000, and $170 billion in New England, the most since 1998, according to Thomson Financial. This year, US mergers are off to one of the fastest starts ever, with $46 billion in deals announced in the first 11 days, according to Thomson.

Full news